INCY · Other

INCYTE CORP

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

• Acquisition / Partnership / DivestitureImportance 65 · Surprise 60
  Incyte acquired Vega Therapeutics, adding VGA039, a Phase 3-ready Protein S modulator for von Willebrand disease. Oppenheimer estimated VGA039 could become a long-term growth asset exceeding $1 billion. The acquisition…

News · 2026-08-06

• Acquisition / Partnership / DivestitureImportance 65 · Surprise 60
  Incyte acquired Vega Therapeutics, adding VGA039, a Phase 3-ready Protein S modulator for von Willebrand disease. Oppenheimer estimated VGA039 could become a long-term growth asset exceeding $1 billion. The acquisition…